Samsara BioCapital
VC · Palo Alto · United States
Stages
Investment region
Industries
Profile
Samsara BioCapital is a venture capital firm based in the United States that primarily invests in biotechnology companies. The firm focuses on creating transformative therapeutics for patients, emphasizing a deep specialization in the life sciences sector. Headquartered in Palo Alto, Samsara BioCapital was founded by Srinivas Akkaraju, a prominent figure with significant expertise in the field of biotechnology venture investing. Samsara BioCapital invests in early to late-stage companies within the life sciences field, with a core emphasis on biotechnology. The firm seeks to back companies in North America, providing capital to fuel the development of groundbreaking therapeutics. While specific check sizes are not disclosed, their focus on therapeutics aligns them with major life sciences investment capabilities. Portfolio highlights include investments in companies such as Acelyrin, Alamar Biosciences, Janux Therapeutics, and Pathalys Pharma. These companies are involved in pioneering work ranging from drug development to innovative biotechnology processes, marking Samsara BioCapital's commitment to reshaping the therapeutic landscape.
Contacts (2)
| Name | Title | Téléphone | ||
|---|---|---|---|---|
| Venture Partner | — | — | — | |
| Managing General Partner | — | — | — |
Name, email and phone are partially hidden. Subscribe to see them in full.